Topics Topics

AstraZeneca vaccines approved for use in Latvia

AstraZeneca confirmed February 8 that vaccines brought in Sunday can be used. The temperature derogation during transportation does not affect the quality of the vaccine in any way, the company  indicated.

The State Agency of Medicines (ZVA) said that the vaccines delivered could be used and could be transferred from the logistics provider's warehouse to the vaccination service providers.

When the vaccines were received, it was found that the supplier had allowed for a derogation from the prescribed procedure: the delivery temperature of the vaccines was half a degree cooler than the prescribed +2 C to +8 C temperature. However, the manufacturer has recognized that the vaccines are safe to use.

The logistics provider will now schedule deliveries and contact all planned vaccination providers, the ZVA said.

Vaccination service providers located in Riga and nearby regions will receive vaccines as early as Tuesday. Delivery is scheduled for Tuesday evening or Wednesday in the farther regions.

Seen a mistake?

Select text and press Ctrl+Enter to send a suggested correction to the editor

Select text and press Report a mistake to send a suggested correction to the editor

Related articles

Please be aware that the LSM portal uses cookies. By continuing to use this site, you agree that we may store and use cookies on your device. Find out more

Accept and continue